Biotech Investor

[Biotech Investor @paul_rudddd]

@Pricerrors Said error and then it was out of stock

[Biotech Investor @paul_rudddd]

@DealsFinderIO Scooped!! Amazing deal!!!!

[Biotech Investor @paul_rudddd]

@thepropdealer CUP

[Biotech Investor @paul_rudddd]

@BiotechAutist PT on CRL? Looking at 2.5P April

[Biotech Investor @paul_rudddd]

@alec93 @BiotechAutist Draft label is not special. Field trial data failed an its riding on a Chamber trial that is supposed to be “supportive” only if real world data shows efficacy

[Biotech Investor @paul_rudddd]

@surferbackpack As this would be, MNPI and would affect investors if it’s essentially a pre-CRL

[Biotech Investor @paul_rudddd]

@surferbackpack This is a great write up! Thanks for the input.

One consideration, I would add:

The Feb 16 date for providing feedback prior to the PDUFA

If the agency identifies major deficiencies that affect the ability to file company would absolutely have to PR that on Monday or Tuesday

[Biotech Investor @paul_rudddd]

@AltimmuneInc Congratulations team! Excellent work on bringing this safe and effective therapy to patients lives.

[Altimmune, Inc. @AltimmuneInc]

We’re pleased to share the U.S. FDA has granted Breakthrough Therapy Designation to our investigational treatment for metabolic dysfunction-associated steatohepatitis (MASH).

Learn more: https://t.co/w9QZSj2Dm9

[Biotech Investor @paul_rudddd]

@AldiUSA new downtown Brooklyn location looks like garbage every day since before the New Year. Trash never gets picked up off the floor and open packages litter the floors. The very few staff are rude and unwelcoming but make sure to let you know it’s 30 minutes before closing.

[Biotech Investor @paul_rudddd]

@fatmaxcat @DealsFinderIO Same. Definitely getting one

[Biotech Investor @paul_rudddd]

@TenangTweet Is this human Monkey Ball?

[Biotech Investor @paul_rudddd]

@DealsFinderIO Code invalid

[Biotech Investor @paul_rudddd]

@DealsFinderIO Great deal!

[Biotech Investor @paul_rudddd]

@gunsnrosesgirl3 Trail mix

[Biotech Investor @paul_rudddd]

@herbthefox1 @VladTheInflator @grok are these claims true?

[Altimmune, Inc. @AltimmuneInc]

Today we hosted our virtual R&D Day where we shared updates and future development plans for #pemvidutide, our GLP-1/glucagon dual receptor agonist for #MASH as well as AUD and ALD.

Watch the full replay here: https://t.co/DV0ad0WgOW

[Biotech Investor @paul_rudddd]

@DealsFinderIO Copped it. Great deal

[Biotech Investor @paul_rudddd]

@MattNachtrab What about the updates from patients in the trials that you were tracking? What possibly could have been the thing affecting the change other than sugar in a pill?